ANDA 84040, held by Ivax Sub Teva Pharms. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 84040 (Sodium Butabarbital), held by Ivax Sub Teva Pharms, was first approved by FDA on May 31, 1974, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sodium Butabarbital30MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters